In-Vitro Diagnostic Regulation
Rare Disease Trials
Research & Development
Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe
Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Latest from Alira Health
Advanced Wound Care Summit
Join us at the Advanced Wound Care Summit July 13 – 14 in Boston.
Business Strategy and Go-to-Market in Medical Robotics
We are pleased to announce that on June 16 we will co-host an online workshop “Business Strategy and Go-to-Market in Medical Robotics” with The Hamlyn Centre for Robotic Surgery.
PSI 2022 Conference
We are pleased to announce that this year we will be joining PSI 2022 Conference, the principal annual event for statisticians in the pharmaceutical industry, as sponsors, exhibitors, and delegates.
Music Beats Cancer Hosts Reception at BIO International Convention in San Diego
Music Beats Cancer hosted a reception fostering a networking community for innovators working on promising solutions for cancer.
Alira Health Acquires RedCrow, an Equity Crowdfunding Platform for Healthcare Startups
We acquired RedCrow, an alternative investment platform that provides individual investors with easy access to expert-vetted healthcare start-ups. The financial terms of the transaction(...)
Alira Health Strengthens Clinical Operations with the Acquisition of Sourcia
We acquired a full-service Contract Research Organization (CRO), Sourcia, that provides services for Phase I to Phase IV clinical trials with a focus on biotech, medical devices, and(...)
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
The Impact of Chip Shortage on the MedTech Sector and RAS Players
Discover the three factors driving the chip shortage, the impact, and what’s next for Robotic and MedTech industry at large.
White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective
In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.